Olathe biotech moves dog cancer treatment closer to market
A Kansas City-area animal health company is ramping up its efforts to take its cancer immunotherapy treatment to market. Elias Animal Health, a subsidiary of Olathe-based TVAX Biomedical Inc., applied for a conditional licensure of its treatment for dogs with bone cancer through the U.S. Department of Agriculture’s Center for Veterinary Biologics. Elias recently completed preliminary studies of its osteosarcoma treatment and will enroll for a pivotal study as the next step. On Thursday, the… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - June 14, 2018 Category: American Health Authors: Elise Reuter Source Type: news

Genetic discovery will help clinicians identify aggressive versus benign bone tumors
(Wellcome Trust Sanger Institute) The first genetic marker for the bone tumor, osteoblastoma, has been discovered by scientists at the Wellcome Sanger Institute and their collaborators. Whole-genome and transcriptome sequencing of human bone tumors revealed that a genetic change that affects the transcription factor, FOS, is a hallmark mutation of osteoblastoma. The results, published in Nature Communications, will help clinicians correctly distinguish benign osteoblastoma tumors from aggressive osteosarcoma tumors and direct the correct treatment. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 12, 2018 Category: Cancer & Oncology Source Type: news

Bone cancer symptoms: Watch out for these less common arthritis-like symptoms
BONE cancer symptoms include aching within the bones, which can be mistaken for arthritis. However, there are also three other symptoms, according to the NHS. (Source: Daily Express - Health)
Source: Daily Express - Health - May 26, 2018 Category: Consumer Health News Source Type: news

Medical News Today: What could cause bone pain?
People may feel aches or pains in their bones for a variety of reasons. Many people worry when they experience bone pain because it can be a sign of bone cancer. For this reason, prompt diagnosis is essential. Learn more about bone pain symptoms, the signs of cancer, and when to see a doctor. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 17, 2018 Category: Consumer Health News Tags: Bones / Orthopedics Source Type: news

Innovative vaccine offers canine cancer patients a shot at a longer, happier life
(University of Pennsylvania) Nicola Mason of the School of Veterinary Medicine is leading a multi-institutional clinical trial evaluating an immunotherapy approach to treat dogs with osteosarcoma, a cancer of the bone. A new $775,000 grant from the Morris Animal Foundation will help her build on her past successes. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 1, 2018 Category: Cancer & Oncology Source Type: news

Girl has leg reattached backwards after cancer surgery
Amelia Eldred who lost her limb to bone cancer has rare procedure which could allow her to dance again. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - April 25, 2018 Category: Consumer Health News Source Type: news

New connections: Ewings sarcomas driver is its Achilles heel
Several studies identify drug combinations that target or exploit the EWS-FLI1 fusion protein to kill Ewing’s sarcoma cells. (Source: Signal Transduction Knowledge Environment)
Source: Signal Transduction Knowledge Environment - April 24, 2018 Category: Science Authors: Ferrarelli, L. K. Tags: STKE Editors ' Choice Source Type: news

The inspirational reason girl, 7, who lost her leg to cancer had her limb attached BACKWARDS
Amelia Eldred, 7, from Tamworth, had her left leg amputated because of a rare form of bone cancer, but her lower leg has been reattached so her ankle can act as a knee when she gets a prosthetic leg. (Source: the Mail online | Health)
Source: the Mail online | Health - April 20, 2018 Category: Consumer Health News Source Type: news

Morris Animal Foundation awards $775K to test osteosarcoma immunotherapy vaccine in dogs
(Morris Animal Foundation) Morris Animal Foundation has awarded a $775,000 grant to the University of Pennsylvania to test a vaccine that could improve longevity and quality of life for dogs with the deadly bone tumor, osteosarcoma. The research team will conduct clinical trials to evaluate a novel immunotherapy treatment which combines a molecule expressed by cancer cells with a modified live form of the bacteria Listeria monocytogenes. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - April 17, 2018 Category: Biology Source Type: news

Pregnant woman, 29, diagnosed with terminal cancer after scan 17 weeks into her first pregnancy
Laura King, a nursery director from Surrey, beat breast cancer in 2017. After the all-clear, she and her husband decided to start a family. Weeks later, she was diagnosed with secondary bone cancer. (Source: the Mail online | Health)
Source: the Mail online | Health - April 13, 2018 Category: Consumer Health News Source Type: news

A potential new therapeutic target for Ewing sarcoma
(IDIBELL-Bellvitge Biomedical Research Institute) IDIBELL researchers correlate EphA2 membrane receptor with the metastatic capacity of tumors in Ewing sarcoma.Ewing sarcoma is the second most frequent bone cancer among children and adolescents, and it is characterized by its aggressiveness and tendency to metastasize.Researchers are currently working on nanoengineering a molecule capable of blocking EphA2 and deliver drugs in a targeted manner.Research was possible thanks to the backing of Alba P é rez Foundation. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 5, 2018 Category: Cancer & Oncology Source Type: news

Greehey Institute team finds link between BRCA1 and Ewing sarcoma
(University of Texas Health Science Center at San Antonio) Scientists with the Greehey Children's Cancer Research Institute at UT Health San Antonio have discovered a surprising connection between a breast cancer protein, BRCA1, and a pediatric cancer called Ewing sarcoma. Their findings were made public March 7 online in the journal Nature. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 7, 2018 Category: Cancer & Oncology Source Type: news

PET imaging could help personalize cancer treatment
Researchers have developed a same-day, noninvasive PET imaging approach to...Read more on AuntMinnie.comRelated Reading: FDG-PET/CT predicts outcomes in pediatric osteosarcoma Artificial intelligence guides lower PET tracer dose PET tracer could better assess lung ailments SNMMI posts criteria for somatostatin receptor PET Deep learning analyzes PET for signs of dementia (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 2, 2018 Category: Radiology Source Type: news

Gemcitabine Plus Sirolimus for Osteosarcoma Gemcitabine Plus Sirolimus for Osteosarcoma
The combination of gemcitabine and sirolimus may be a safe and effective option for patients with relapsed unresectable osteosarcoma.Annals of Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 23, 2018 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Scientists tackle the aberrant epigenetic programming underlying childhood cancers
(Write Science Right) Researchers at UFRGS and the US NIH have targeted proteins that regulate chromatin in Ewing sarcoma cells, hindering malignant tumor growth. They induced chromatic relaxation by treating the cells with histone deacetylase inhibitors, reducing expression of the EWSR1-FLI-1 oncogene and other pluripotency/cell viability genes, while impairing sarcoma cell survival and growth. Decreased survival of stem-like cancer cells and re-expression of a neuronal differentiation marker were also observed. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 20, 2018 Category: International Medicine & Public Health Source Type: news

Marijuana laws in New Jersey are loosening restrictions in the wake of a young boy’s tragic death to rare cancer
(Natural News) Phil Murphy, New Jersey’s governor, has recently signed “an executive order for broader medical marijuana access.” Jake Honig, a seven-year-old boy who died last January due to a rare bone cancer, seems to have moved the governor to make this particular decision. Jake, who received the nickname “Jake the Tank” because of the... (Source: NaturalNews.com)
Source: NaturalNews.com - February 13, 2018 Category: Consumer Health News Source Type: news

Unique research approach finds FDA-approved drug shuts down Ewing sarcoma cells in lab
(Georgetown University Medical Center) Based on a novel approach to drug discovery, researchers at Georgetown Lombardi Comprehensive Cancer Center say an agent approved to treat a type of leukemia might also help young people with a much rarer and aggressive form of cancer, Ewing sarcoma. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 30, 2018 Category: Cancer & Oncology Source Type: news

Alex Huang, M.D., Ph.D., receives $450,000 from Pediatric Cancer Research Foundation
(Case Western Reserve University) Leading cancer researcher, Alex Huang M.D., Ph.D., has received a $450,000 Basic Science grant from Pediatric Cancer Research Foundation to study targeted approaches for effectively eliminating metastatic osteosarcoma. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 25, 2018 Category: International Medicine & Public Health Source Type: news

Cancer researchers hit a bullseye with new drug target for Ewing sarcoma
(Boston Children's Hospital) Kimberly Stegmaier of Dana-Farber/Boston Children's Cancer and Blood Disorders Center and collaborators have found that Ewing sarcoma cells die if an enzyme called CDK12 is knocked out genetically or chemically inhibited. What's more, when a CDK12 inhibitor is combined with another drug, called a PARP inhibitor, the two drugs double down to deliver a lethal punch to Ewing sarcoma cells. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - January 25, 2018 Category: Biology Source Type: news

FDG-PET/CT predicts outcomes in pediatric osteosarcoma
The best way to predict a good outcome for pediatric patients with osteosarcoma...Read more on AuntMinnie.comRelated Reading: UC Davis group reports progress on total-body PET/CT FDA issues guidance on lowering pediatric x-ray dose FDG-PET, DWI-MRI help predict osteosarcoma chemo response FDG-PET/CT a good option for imaging pediatric osteosarcoma (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 19, 2018 Category: Radiology Source Type: news

Promising Experimental Drug Treating Dogs With Cancer
NORTH GRAFTON (CBS) – When it comes to cancer research, dogs just might be the key to unlock vital clues needed to find a cure. Veterinarians in central Massachusetts are excited about some recent results and it’s also making for some extremely thankful pet owners. “They gave me my best friend back and they gave him more time, quality time,” said Edward Sloan, whose dog, Dozer, a 7-year-old bull mastiff, became sick last fall. “All of sudden he went blind, overnight,” Sloan said. “He was scared.  He was sad.” Dozer had cancer. Dozer, a 7-year-old bull mastiff, is be...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - January 13, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health Local News Syndicated Local Cancer Dr. Mallika Marshall Source Type: news

Molecular imaging technique identifies lung nodules for resection in osteosarcoma patient
(SPIE--International Society for Optics and Photonics) Utility of near-infrared molecular imaging in a patient undergoing pulmonary metastasectomy for osteosarcoma has been reported by researchers from Perelman School of Medicine at the University of Pennsylvania and Purdue University. The work is reported in an article in the Journal of Biomedical Optics published this week by SPIE, the international society for optics and photonics. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 5, 2018 Category: International Medicine & Public Health Source Type: news

Aratana nears approval for canine cancer vaccine
Aratana Therapeutics Inc.'s cancer immunotherapy drug for dogs gained a conditional license from the U.S. Department of Agriculture, the company announced Wednesday. To gain full licensure, Aratana (Nasdaq; PETX) will start another field study in early 2018. The vaccine initially will be available for purchase at 12 veterinary oncology practices participating in the study. It's designed to treat dogs with bone cancer after the tumor is surgically removed. It works using listeria, a type of bacteria,… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - December 21, 2017 Category: American Health Authors: Elise Reuter Source Type: news

Aratana nears approval for canine cancer vaccine
Aratana Therapeutics Inc.'s cancer immunotherapy drug for dogs gained a conditional license from the U.S. Department of Agriculture, the company announced Wednesday. To gain full licensure, Aratana (Nasdaq; PETX) will start another field study in early 2018. The vaccine initially will be available for purchase at 12 veterinary oncology practices participating in the study. It's designed to treat dogs with bone cancer after the tumor is surgically removed. It works using listeria, a type of bacteria,… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 21, 2017 Category: Biotechnology Authors: Elise Reuter Source Type: news

Aratana nears approval for canine cancer vaccine
Aratana Therapeutics Inc.'s cancer immunotherapy drug for dogs gained a conditional license from the U.S. Department of Agriculture, the company announced Wednesday. To gain full licensure, Aratana (Nasdaq; PETX) will start another field study in early 2018. The vaccine initially will be available for purchase at 12 veterinary oncology practices participating in the study. It's designed to treat dogs with bone cancer after the tumor is surgically removed. It works using listeria, a type of bacteria,… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - December 21, 2017 Category: Health Management Authors: Elise Reuter Source Type: news

N.M. Paramedic Helps Young Cancer Patient With His 'Bucket List'
RIO RANCHO, N.M. (KRQE) –They met only once, but a strong bond ties a local paramedic to her former patient. Now, she’s hoping to help grant a big wish for a child battling cancer. Paramedic Jennifer Saiz is a cancer survivor but her patient is still in the fight. She says his joyful spirit touched her so much, she wanted to help check off an item on his bucket list. At the Dimas’ household, there are plenty of presents wrapped under the tree. But what’s on 10-year-old Elijah’s Christmas list can’t be tied with a bow. “Visit the Pokémon center in Japan, get Nickelodeon...
Source: JEMS Administration and Leadership - December 13, 2017 Category: Emergency Medicine Authors: Francesca Washington, KRQE Tags: News Videos Administration and Leadership Source Type: news

PharmaMar presents positive results from a Phase II study of PM1183 in Ewing's sarcoma
(Pharmamar) PharmaMar (MSE:PHM) has presented positive results from a Phase II study of lurbinectedin in Ewing ´ s sarcoma at the Connective Tissue Oncology Society ´ s (CTOS) International Congress that took place in Hawaii from the 8th to the 11th of November. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 13, 2017 Category: Cancer & Oncology Source Type: news

HKBU Chinese medicine scholars develop HKBU Chinese medicine scholars develop
(Hong Kong Baptist University) Chinese Medicine scholars at Hong Kong Baptist University (HKBU) have succeeded in developing a novel targeted delivery system for CRISPR/Cas9 to achieve therapeutic genome editing of VEGFA in osteosarcoma (OS). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 10, 2017 Category: International Medicine & Public Health Source Type: news

With three products out, Aratana chases its fourth: a canine cancer drug
With its third FDA-approved drug on the market, Aratana Therapeutics is hunting its next product, a canine cancer immunotherapy treatment. The treatment, called AT-014, would be used to treat bone cancer, or osteosarcoma, in dogs. After a tumor is removed, a vaccine is used to prime the dog’s immune system to target any remaining cancer. Aratana (Nasdaq: PETX) expects to obtain conditional licensure for the treatment from the U.S . Department of Agriculture before the end of 2017, which would… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - November 7, 2017 Category: Pharmaceuticals Authors: Elise Reuter Source Type: news

Two classes of GGAA-microsatellites in a Ewing sarcoma context
(Nationwide Children's Hospital) In a study published in PLOS ONE, researchers describe two types of GGAA-microsatellites and their roles in EWS/FLI binding and gene regulation in Ewing sarcoma. Ewing sarcoma is the second most common pediatric bone malignancy. It is initiated by chromosomal translocation t(11;22)(q24;q12), which creates the fusion protein and oncogenic driver EWS/FLI. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 1, 2017 Category: Cancer & Oncology Source Type: news

Just-in-time 3-D implants set to transform tumor surgery
(RMIT University) The project team will combine 3-D printing, robotic surgery and advanced manufacturing to create tailored implants for patients with bone cancer, dramatically improving patient and healthcare outcomes. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 29, 2017 Category: Cancer & Oncology Source Type: news

Three of the most deadly cancers get critical funding for research
Immunotherapy for leukemia patients has been nothing short of a miracle. Now scientists hope to use that science and other forms of gene therapy to tackle three of the deadliest forms of cancer: glioblastoma (brain cancer), sarcoma (bone cancer) and ovarian cancer. Three scientists have received $1.3 million in critical funding from the Alliance for Cancer Gene Therapy (ACGT), the nation's only nonprofit dedicated exclusively to cell and gene therapies for cancer. (Source: World Pharma News)
Source: World Pharma News - October 18, 2017 Category: Pharmaceuticals Tags: Featured Development Research and Development Source Type: news

Living With Cancer: Cancer Humor
Cracking up may be a better option than breaking down, or so three recent books by young people with cancer suggest. (Source: NYT Health)
Source: NYT Health - October 12, 2017 Category: Consumer Health News Authors: SUSAN GUBAR Tags: Breast Cancer Books and Literature Ewing's Sarcoma (Disease) Comedy and Humor Riggs, Nina (1977-2017) Harrison, Teva (1976- ) Ritvo, Max (1990-2016) Source Type: news

New drug hope for rare bone cancer patients
Patients with a rare bone cancer of the skull and spine - chordoma - could be helped by existing drugs, suggest scientists from the Wellcome Trust Sanger Institute, University College London Cancer Institute and the Royal National Orthopaedic Hospital NHS Trust. In the largest genomics study of chordoma to date, published today in Nature Communications, scientists show that a group of chordoma patients have mutations in genes that are the target of existing drugs, known as PI3K inhibitors. (Source: World Pharma News)
Source: World Pharma News - October 12, 2017 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

New drug hope for rare bone cancer patients
(Wellcome Trust Sanger Institute) Patients with a rare bone cancer of the skull and spine -- chordoma -- could be helped by existing drugs, suggest scientists from the Wellcome Trust Sanger Institute, University College London Cancer Institute and the Royal National Orthopaedic Hospital NHS Trust. In the largest genomics study of chordoma to date, published today in Nature Communications, scientists show that a group of chordoma patients have mutations in genes that are the target of existing drugs, known as PI3K inhibitors. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 12, 2017 Category: Cancer & Oncology Source Type: news

WATCH: Friends 'just keep swimming,' despite blindness and bone cancer
Two teenagers swim together and support each other as one faces progressive blindness and the other fights bone cancer. (Source: ABC News: Health)
Source: ABC News: Health - October 10, 2017 Category: Consumer Health News Tags: GMA Source Type: news

Friends 'just keep swimming' despite blindness and bone cancer
Two teenagers swim together and support each other as they face progressive blindness and bone cancer, respectively. (Source: ABC News: Health)
Source: ABC News: Health - October 10, 2017 Category: Consumer Health News Tags: Health Source Type: news

WATCH: Friends "Just Keep Swimming" despite blindness and bone cancer
Two teenagers swim together and support each other as one faces progressive blindness and the other fights bone cancer. (Source: ABC News: Health)
Source: ABC News: Health - October 10, 2017 Category: Consumer Health News Tags: GMA Source Type: news

Two agents deliver knockout punches to Ewing sarcoma
(Georgetown University Medical Center) When combined with an already FDA-approved chemotherapy, a novel agent developed by researchers at Georgetown Lombardi Comprehensive Cancer Center, appears to halt the ability of Ewing sarcoma to grow and progress. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 3, 2017 Category: Cancer & Oncology Source Type: news

Inhibition of the oncogenic fusion protein EWS-FLI1 causes G2-M cell cycle arrest and enhanced vincristine sensitivity in Ewings sarcoma
Ewing’s sarcoma (ES) is a rare and highly malignant cancer that grows in the bones or surrounding tissues mostly affecting adolescents and young adults. A chimeric fusion between the RNA binding protein EWS and the ETS family transcription factor FLI1 (EWS-FLI1), which is generated from a chromosomal translocation, is implicated in driving most ES cases by modulation of transcription and alternative splicing. The small-molecule YK-4-279 inhibits EWS-FLI1 function and induces apoptosis in ES cells. We aimed to identify both the underlying mechanism of the drug and potential combination therapies that might enhance its...
Source: Signal Transduction Knowledge Environment - October 3, 2017 Category: Science Authors: Zöllner, S. K., Selvanathan, S. P., Graham, G. T., Commins, R. M. T., Hong, S. H., Moseley, E., Parks, S., Haladyna, J. N., Erkizan, H. V., Dirksen, U., Hogarty, M. D., Üren, A., Toretsky, J. A. Tags: STKE Research Articles Source Type: news

i-Fect Delivers Plasmids!
Important for Gene Expression Studies.I have posted many examples of how our customers usei-FectTM  and otherTransfection Solutions for Gene Manipulation Studies. There are also manypublications.Here we feature how i-Fect was used to delivery plasmids to the CNS: Sara Elramah, Mar ía José López-González, Matthieu Bastide, Florence Dixmérias, Olivier Roca-Lapirot, Anne-Cécile Wielanek-Bachelet, Anne Vital, Thierry Leste-Lasserre, Alexandre Brochard, Marc Landry& Alexandre Favereaux.Spinal miRNA-124 regulates synaptopodin and nociception in an animal model of bone ...
Source: Neuromics - September 21, 2017 Category: Neuroscience Tags: Bone Cancer Pain cancer biology iFect Plasmids Transfection Reagents Source Type: news

i-Fect Deliver Plasmids to the CNS
Important for Gene Expression Studies.I have posted many examples of how our customers usei-FectTM  and otherTransfection Solutions for Gene Manipulation Studies. There are also manypublications.Here we feature how i-Fect was used to delivery plasmids to the CNS: Sara Elramah, Mar ía José López-González, Matthieu Bastide, Florence Dixmérias, Olivier Roca-Lapirot, Anne-Cécile Wielanek-Bachelet, Anne Vital, Thierry Leste-Lasserre, Alexandre Brochard, Marc Landry& Alexandre Favereaux.Spinal miRNA-124 regulates synaptopodin and nociception in an animal model of bone ...
Source: siRNA and DsiRNA Transfection Efficiency - September 21, 2017 Category: Neuroscience Tags: C iFect Plasmid Transfection Plasmid Vector shRNA plasmids Source Type: news

Jess Quinn who lost her leg to bone cancer talks struggles
Jessica Quinn, from New Zealand, who lost her leg to cancer has opened up about her struggles with body image - and how she was able to bounce back by embracing her  prosthetic limb. (Source: the Mail online | Health)
Source: the Mail online | Health - July 31, 2017 Category: Consumer Health News Source Type: news

Osteosarcoma and Malignant Fibrous Histiocytoma
of Bone (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - July 31, 2017 Category: General Medicine Source Type: news

Leicester cancer boy heading home after treatment in US
Alex Goodwin, from Rugby, England, was diagnosed with Ewing's Sarcoma last year after months of agony in his joints and muscles. He finished treatment earlier this month and is headed home in August. (Source: the Mail online | Health)
Source: the Mail online | Health - July 28, 2017 Category: Consumer Health News Source Type: news

Elevated cholesterol's link with canine cancer includes a better prognosis
(Oregon State University) Usually thought of as a health detriment, elevated cholesterol may play a role in longer survival times for dogs with a common form of bone cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 25, 2017 Category: Cancer & Oncology Source Type: news

Dogs assist the fight against bone cancer
Comparative oncology, a rapidly-growing field of cancer research, pairs veterinarians with human doctors in the fight against cancer. Because certain cancers in dogs and people share striking similarities, the hope is that a new treatment for dogs, if successful, could be applied to people, too. Susan Spencer reports. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - July 23, 2017 Category: Consumer Health News Source Type: news

On The Horizon: How dogs may help fight bone cancer
Veterinarians team up with cancer doctors in the field of comparative oncology to find a cure for osteosarcoma (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - July 22, 2017 Category: Consumer Health News Source Type: news

Tumor-targeting drug shows potential for treating bone cancer patients
(University of Texas M. D. Anderson Cancer Center) The treatment of osteosarcoma, the most common tumor of bone, is challenging. A study led by The University of Texas MD Anderson Cancer Center found a drug known as bone metastasis-targeting peptidomimetic (BMTP-11) has potential as a new therapeutic strategy for this devastating illness. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 12, 2017 Category: International Medicine & Public Health Source Type: news